MedDataX Logo

Societal Burden Associated With Type 1 Diabetes in Canada

NCT ID: NCT06786130

Last Updated: 2025-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-09

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this observational study is to estimate the burden of T1D on caregivers of patient with T1D in terms of work productivity, healthcare resource utilization and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 1 Diabetes Mellitus Quality of Life (QOL) Work Productivity Caregiver Subjective Burden

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

observational quality of life caregiver work productivity real-world

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caregiver of child with T1D

Caregiver of child with T1D diagnosed within the past 2 years

observational study

Intervention Type OTHER

This is an observational study in which participants complete PRO questionnaires via a web platform. No medical intervention or medication is involved.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observational study

This is an observational study in which participants complete PRO questionnaires via a web platform. No medical intervention or medication is involved.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Parental caregiver of a child recently diagnosed (\<= 2 years) with T1D before study inclusion;
2. Age ≥18 ;
3. Residence in the Canada;
4. Willingess to complete a 20-minute survey
5. Ability to read and understand French or English;
6. Signature of informed consent form (ICF)

Exclusion Criteria

1\. Participation in a clinical trial.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanofi

INDUSTRY

Sponsor Role collaborator

PeriPharm

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PROxy Network, an initiative of PeriPharm Inc.

Montreal, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Catherine Beauchemin, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BOD0250

Identifier Type: -

Identifier Source: org_study_id